| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2012PLoSO...744575R |
| P356 | DOI | 10.1371/JOURNAL.PONE.0044575 |
| P932 | PMC publication ID | 3440341 |
| P698 | PubMed publication ID | 22984529 |
| P5875 | ResearchGate publication ID | 230865136 |
| P50 | author | Niels Obel | Q64145165 |
| Jan Gerstoft | Q114302316 | ||
| P2093 | author name string | Court Pedersen | |
| Elisabeth R Mathiesen | |||
| Gitte Kronborg | |||
| Line D Rasmussen | |||
| P2860 | cites work | Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies | Q24597052 |
| Metabolic effects of indinavir in healthy HIV-seronegative men | Q28366603 | ||
| Incidence and risk factors for new-onset diabetes in HIV-infected patients: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) study | Q31146395 | ||
| The Danish National Hospital Register. A valuable source of data for modern health sciences. | Q31380260 | ||
| Diabetes mellitus, insulin resistance, and metabolic syndrome in HIV-positive patients in South India | Q34622631 | ||
| The effects of opiate use and hepatitis C virus infection on risk of diabetes mellitus in the Women's Interagency HIV Study. | Q34753973 | ||
| Indinavir acutely inhibits insulin-stimulated glucose disposal in humans: a randomized, placebo-controlled study | Q35195035 | ||
| Mechanisms and strategies for insulin resistance in acquired immune deficiency syndrome | Q35207207 | ||
| Incident hyperglycaemia among older adults with or at-risk for HIV infection. | Q36554781 | ||
| Insulin Resistance and Diabetes Mellitus in HIV-Infected Patients Receiving Antiretroviral Therapy | Q37120773 | ||
| HIV infection and the risk of diabetes mellitus. | Q37365031 | ||
| Oral glucose tolerance and insulin sensitivity are unaffected by HIV infection or antiretroviral therapy in overweight women | Q39714658 | ||
| The Danish Registry on Regular Dialysis and Transplantation: completeness and validity of incident patient registration. | Q44371673 | ||
| Stavudine or indinavir-containing regimens are associated with an increased risk of diabetes mellitus in HIV-infected individuals | Q44576848 | ||
| Protease inhibitor use and the incidence of diabetes mellitus in a large cohort of HIV-infected women | Q44696436 | ||
| A Danish diabetes risk score for targeted screening: the Inter99 study | Q44779312 | ||
| No evidence of a higher 10 year period prevalence of diabetes among 77,885 twins compared with 215,264 singletons from the Danish birth cohorts 1910-1989. | Q44947307 | ||
| Prevalence of diabetes mellitus and dyslipidemia among antiretroviral naive patients co-infected with hepatitis C virus (HCV) and HIV-1 compared to patients without co-infection | Q45476297 | ||
| Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study | Q46175058 | ||
| Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study | Q46505818 | ||
| Epidemiological correlates of NIDDM in Hispanics, whites, and blacks in the U.S. population | Q46547840 | ||
| Demographics of HIV-1 infection in Denmark: results from the Danish HIV Cohort Study | Q46648502 | ||
| Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the Multicenter AIDS Cohort Study | Q46653141 | ||
| Survival of persons with and without HIV infection in Denmark, 1995-2005. | Q50544706 | ||
| Cohort profile: the Danish HIV cohort study. | Q50548255 | ||
| The Danish Civil Registration System. | Q50554185 | ||
| The Danish National Prescription Registry. | Q50554204 | ||
| Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment. | Q51388029 | ||
| Treatment with protease inhibitors associated with peripheral insulin resistance and impaired oral glucose tolerance in HIV-1-infected patients. | Q54117055 | ||
| Factors Associated with the Incidence of Type 2 Diabetes Mellitus in HIV-Infected Participants in the Swiss HIV Cohort Study | Q56529459 | ||
| The continuing epidemics of obesity and diabetes in the United States | Q56890709 | ||
| Risk factors for incident diabetes mellitus among HIV-infected patients receiving combination antiretroviral therapy in Taiwan: a case-control study | Q57610535 | ||
| Fat distribution and metabolic changes in patients with HIV infection | Q73343740 | ||
| Protease inhibitor-associated hyperglycaemia | Q73685253 | ||
| Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: a 5-year cohort study | Q73977354 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 9 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | e44575 | |
| P577 | publication date | 2012-09-12 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study | |
| P478 | volume | 7 |
| Q36022338 | A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon |
| Q28385694 | A cross-sectional, facility based study of comorbid non-communicable diseases among adults living with HIV infection in Zimbabwe |
| Q57173878 | Abdominal fat depots, insulin resistance, and incident diabetes mellitus in women with and without HIV infection |
| Q30244921 | Alcohol Use and Human Immunodeficiency Virus (HIV) Infection: Current Knowledge, Implications, and Future Directions |
| Q34724872 | Antiretroviral therapy modifies the genetic effect of known type 2 diabetes-associated risk variants in HIV-infected women |
| Q90743449 | Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in Greece |
| Q28541867 | Comorbidities among the HIV-infected patients aged 40 years or older in Taiwan |
| Q90612746 | Comorbidity of HIV, hypertension, and diabetes and associated factors among people receiving antiretroviral therapy in Bahir Dar city, Ethiopia |
| Q41982706 | Cooccurrences of Putative Endogenous Retrovirus-Associated Diseases |
| Q36208301 | Demographical, Viro-Immunological, Clinical and Therapeutical Characteristics of HIV-Infected Patients in an "Epidemiologically Unexplored" Region of Italy (Calabria Region): the CalabrHIV Cohort |
| Q57180651 | Diabetes and HIV |
| Q46765257 | Diabetes, metabolic syndrome and dyslipidemia in people living with HIV in Africa: re-emerging challenges not to be forgotten |
| Q27014697 | Diagnosing and managing diabetes in HIV-infected patients: current concepts |
| Q47219853 | Endocrinological aspects of HIV infection |
| Q47275628 | Excess Clinical Comorbidity Among HIV-Infected Patients Accessing Primary Care in US Community Health Centers |
| Q28553878 | Fifteen-Year Trends in the Prevalence of Diabetes among Hospitalized HIV-Infected Patients in Spain (1997-2012) |
| Q42259738 | Global confluence of infectious and non-communicable diseases -- the case of type 2 diabetes |
| Q41716612 | Glycaemic profile changes by highly active antiretroviral therapy in human immunodeficiency virus-infected patients. |
| Q30239101 | HIV and its relationship to insulin resistance and lipid abnormalities. |
| Q27008915 | HIV infection and cardiovascular disease |
| Q36327164 | HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammation |
| Q37176327 | High glucose enhances HIV entry into T cells through upregulation of CXCR4. |
| Q93142174 | Human Immunodeficiency Virus Infection and the Endocrine System |
| Q38821848 | Hypertension Is a Key Feature of the Metabolic Syndrome in Subjects Aging with HIV |
| Q55342018 | Immune reconstitution in ART treated, but not untreated HIV infection, is associated with abnormal beta cell function. |
| Q40747316 | Impact of Age-related Comorbidities on Five-year Overall Mortality among Elderly HIV-Infected Patients in the Late HAART Era--Role of Chronic Renal Disease |
| Q54224356 | Impact of HIV and Type 2 diabetes on Gut Microbiota Diversity, Tryptophan Catabolism and Endothelial Dysfunction. |
| Q47118049 | Incidence of diabetes mellitus and factors associated with its development in HIV-positive patients over the age of 50. |
| Q61910384 | Infections virales et diabète en Afrique |
| Q37627175 | Is diabetes prevalence higher among HIV-infected individuals compared with the general population? Evidence from MMP and NHANES 2009-2010. |
| Q35860942 | Late Antiretroviral Therapy (ART) Initiation Is Associated with Long-Term Persistence of Systemic Inflammation and Metabolic Abnormalities |
| Q57815879 | Magnitude and associated factors of diabetes mellitus and hypertension among adult HIV-positive individuals receiving highly active antiretroviral therapy at Jugal Hospital, Harar, Ethiopia |
| Q58588489 | Metabolic risk factors in young adults infected with HIV since childhood compared with the general population |
| Q26853470 | Metabolic syndrome, diabetes, and cardiovascular risk in HIV |
| Q64079045 | Noncommunicable disease burden among HIV patients in care: a national retrospective longitudinal analysis of HIV-treatment outcomes in Kenya, 2003-2013 |
| Q89606626 | Prevention of cardiovascular disease among people living with HIV in sub-Saharan Africa |
| Q38596011 | Risk of Cardiovascular Disease in an Aging HIV Population: Where Are We Now? |
| Q58759355 | Risk of diabetes mellitus in HIV-infected patients receiving highly active antiretroviral therapy: A nationwide population-based study |
| Q40101352 | The Aging Population with HIV Infection |
| Q30248586 | The global diabetes epidemic: what does it mean for infectious diseases in tropical countries? |
| Q37133239 | The penumbra of randomized control trials |
| Q40279993 | The yield and feasibility of integrated screening for TB, diabetes and HIV in four public hospitals in Ethiopia |
| Q54257862 | Type 2 diabetes prevalence and its risk factors in HIV: A cross-sectional study. |
| Q39772256 | Weight Gain and Incident Diabetes Among HIV-Infected Veterans Initiating Antiretroviral Therapy Compared With Uninfected Individuals. |
Search more.